The rational use of medicines and diagnostics will directly benefit policyholders by lowering their out-of-pocket expenses. At the same time, streamlined care will result in faster recovery and fewer complications, believes Roy.
Related Posts
Global study projects 51 lakh in India could be at risk of chikungunya every year in long-term
Post Views: 19 The study, led by researchers at the…
Health experts double down on minimal meat-eating call
Post Views: 16 A healthy diet is “predominantly plant-based, with…
Sun Pharma launches Leqselvi in the US
Post Views: 33 Sun Pharma has launched Leqselvi (deuruxolitinib, 8 mg)…